Bostik was a game-changing acquisition and the figures are dominated by this effect. In Q4, sales clearly improved +23% to €1,760m and the gross profit margin strongly improved from 15.5% to 18.0%. EBITDA went up +23% to €195m and net income attributable to shareholders nearly doubled (€49m after €27m). Operating CF more than doubled (€380m after €162m), driven by higher D/A and, additionally, propelled by a stronger NWC inflow (€205m after €61m), helpe
03 Mar 2016
Is everything going to be alright?
Sign up to access
Get access to our full offering from over 30 providers
Get access to our full offering from over 30 providers
Is everything going to be alright?
Arkema SA (AKE:WBO) | 0 0 0.4% | Mkt Cap: 7,655m
- Published:
03 Mar 2016 -
Author:
Martin Schnee -
Pages:
3
Bostik was a game-changing acquisition and the figures are dominated by this effect. In Q4, sales clearly improved +23% to €1,760m and the gross profit margin strongly improved from 15.5% to 18.0%. EBITDA went up +23% to €195m and net income attributable to shareholders nearly doubled (€49m after €27m). Operating CF more than doubled (€380m after €162m), driven by higher D/A and, additionally, propelled by a stronger NWC inflow (€205m after €61m), helpe